Viewing Study NCT02084732


Ignite Creation Date: 2025-12-24 @ 9:37 PM
Ignite Modification Date: 2026-02-22 @ 1:34 AM
Study NCT ID: NCT02084732
Status: COMPLETED
Last Update Posted: 2019-11-13
First Post: 2014-03-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study
Sponsor: Instituto Nacional de Cancerologia, Columbia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module